20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world.
Takeda Pharmaceutical Co Ltd (TAK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,297,805 | $204,029,677 | 0.05% | |
| 2. | 8,167,393 | $116,548,698 | 1.84% | |
| 3. | 4,847,535 | $69,174,354 | 0% | |
| 4. | 4,302,562 | $61,397,569 | 0.01% | |
| 5. | 2,651,265 | $37,833,550 | 0.57% |
News See All
5 Best Japanese Stocks To Buy In 2024
Takeda Pharmaceutical Company Limited (NYSE:TAK) is a global pharmaceutical company engaged in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products.
20 Fastest Growing Biotech Companies in the US
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
30 Most Valuable Drug Companies in 2024
In this article, we will take a look at the 30 most valuable drug companies in 2024.
13 Most Promising Healthcare Stocks According to Analysts
In this article, we discuss the 13 most promising healthcare stocks according to analysts.
30 Largest Pharmaceutical Companies in the World
In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2023 Earnings Call Transcript
Christopher O'Reilly: Thank you very much for joining us out of your busy schedule today for the earnings call for Second Quarter Fiscal 2023 with Takeda Pharmaceutical Company Limited.
10 Best Japanese Stocks To Invest in 2023
Japan is one of the most technologically advanced nations in the world and also one of the biggest economies.
Top 30 Oncology Companies in the World
In this article, we shall cover the top 30 oncology companies in the world.
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q1 2023 Earnings Call Transcript
Christopher O'Reilly: Thank you very much for joining us today despite a very busy schedule for this FY 2023 Q1 earnings announcement. My name is O'Reilly. I am the head of IR.
Billionaire Hedge Funds
